Lorraine Boyle
Lorraine BoyleManaging Director

Meet Lorraine

Lorraine is the Managing Director at case Market Access Consulting Inc.

Lorraine is a former registered nurse with over 25 years of experience in the Canadian public health care system and biopharmaceutical industry. Her experience spans sales, marketing, market access, government relations and patient advocacy.

Therapeutic areas of experience and expertise include:

  • Neurology: multiple sclerosis and the rare disease, spinal muscular atrophy (SMA) and Alzheimer’s Disease
  • Hematology: hemophilia and anemia
  • Oncology: neuro and dermatologic, supportive care
  • Nephrology
  • Critical care

Lorraine’s strengths include integrating the patient and clinician perspective along with the clinical and economic value proposition to address payer information requirements for reimbursement decision making. She believes that the patient community perspective and integrating the community voice is a critical element for a successful strategy.

In the Canadian environment, resource challenges and competing funding priorities require novel approaches for a successful health technology assessment and reimbursement strategy.

Lorraine’s expertise has evolved with the development of creative approaches for new innovations that face uncertain health technology assessment and reimbursement pathways. She has partnered with patient, clinician and payer stakeholders to build mutually acceptable solutions for successful reimbursement outcomes.

What case Offers:

case offers a unique depth and breadth of experience, insights and expertise from the public hospital and private biopharmaceutical sectors in Canada.

Lorraine brings 10 years as a registered nurse from several major teaching tertiary care hospitals in Hamilton, Ottawa and London Ontario where she held a variety of roles in clinical practice, education and administrative leadership.

Additionally, Lorraine has approximately 15 years in market access, reimbursement, stakeholder relations, marketing and sales in the biopharmaceutical corporate sector.

What case Provides:

With this profile, case provides context and perspective to your market access strategy that considers business priorities using a multi-stakeholder lens including:

  • Patients – Patients and individuals that could be impacted by treatment

  • Clinicians – Clinicians who practice in the treatment therapeutic area

  • Payers – Public provincial/federal payers and private payers whose budgets will be impacted

  • Health Policy – Health policy individuals involved in decision making

  • Government – Other government agencies/individuals

Discover The Link

Case Market Access Consulting Inc. links biopharmaceutical teams and their partners.